Agendia

Agendia is the only molecular diagnostics company focused solely on breast cancer. With their groundbreaking genomic testing, they generate reliable and meaningful clinical data about the unique biology of a woman’s breast cancer.

Industries

Biotechnology

Headquarters

Irvine, United States

Stage

Private Equity

Employees

51-200

Links

Org chart

Mark R. Straley

Chief Executive Officer

Collapse

Kurt Becker

Chief Operations Officer

Brian Dow

Chief Financial Officer

William Audeh

Chief Medical Officer

Roopom Banerjee

Chief Strategy Officer & Head Of Business Development

Bastiaan Van Der Baan

Chief Clinical & Business Development Officer

Laura van ‘t Veer

Chief Research Officer & Co‑founder

René Bernards

Chief Scientific Officer & Co‑founder

Christy Garcia

VP, Compliance

Teams

View all

Leadership Team

9 members

CEO and Executive Team

8 members

Board of Directors

4 members

Founding Team

2 members

Discover similar companies

Cytodyn

Vancouver, United States · Post IPO Equity

Ultivue

Cambridge, United States · Series D

Adaptive Phage Therapeutics

Gaithersburg, United States · Grant

Regeneron

Tarrytown, United States · Post IPO Equity

Be Bio

Cambridge, United States · Series B

Verve Therapeutics

Cambridge, United States · IPO

Biogen

Cambridge, United States

Century Therapeutics

Philadelphia, United States · Post IPO Equity

Guardant Health

Redwood City, United States · Venture

Genentech

South San Francisco, United States · Venture

Natera

Austin, United States · Post IPO Equity

Biomason

Durham, United States · Series C

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.